mRNA-1273 continues to be efficacious at five months
Sep 27, 2021
The efficacy of mRNA-1273, the Moderna vaccine, was 93.2% for preventing COVID-19 illness and 98.2% for preventing severe COVID-19.
Testimony: OSHA must take introspective look to ensure worker safety in future health crises
By
Kimberly Bonvissuto
May 26, 2022
The federal agency charged with protecting workplace safety needs to take a hard look at itself to more effectively ensure worker safety and health during a future crisis, according to testimony during...
Delta variant accounts for most breakthrough SARS-CoV-2 cases
Aug 03, 2021
The delta variant was identified in 89% of patients with breakthrough infection; four of five hospitalized patients were vaccinated.
Fewer deaths reported with enrollment in COVID-19 remote monitoring
Nov 18, 2021
The remote monitoring service, COVID Watch, reduced deaths at 30 and 60 days and was associated with presentation to the emergency department sooner.
COVID-19 vaccine effectiveness changing with delta predominance
Sep 14, 2021
Vaccine protection against SARS-CoV-2 infection declined; protection remained higher against hospitalization, death.
Most immunosuppressive meds not tied to worse COVID-19 outcomes
Dec 01, 2021
Except for rituximab, no increased risk was seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy.
Decline in infectious conjunctivitis during COVID-19 pandemic
Nov 29, 2021
There was a decrease in emergency department encounters for nonallergic conjunctivitis after the adoption of public health measures to curb COVID-19.
Effectiveness of Ad26.COV2.S vaccine stable for six months
Mar 22, 2022
A single dose of the Johnson & Johnson vaccine was 74% and 81% effective for preventing COVID-19 infection and hospitalizations, respectively, in the U.S. before and during delta variant surge.
Fourth COVID-19 vaccine dose safe for immunocompromised
Jul 18, 2022
Local and systemic reactions were reported less frequently after the fourth dose versus dose 3 of the primary vaccination series.
COVID-19 vaccine booster dose cuts infection in those 60 and older
Sep 17, 2021
A large Israeli study shows a reduction in confirmed infection and severe illness among adults 60 years of age and older.